Literature DB >> 12084683

The impact of genomics on global health.

Tikki Pang1.   

Abstract

Ensuring that advances in genomics are applied to the health improvement of people living in developing countries is an important contemporary challenge. In the near term, such advances are likely to alleviate infectious diseases, with longer-term benefits envisaged for chronic disorders. To ensure that benefits are shared by developing countries, attention must be paid to complex ethical, legal, social, and economic issues, as well as to public education and engagement. Creative and equitable international mechanisms and goodwill are needed to turn high hopes into reality and allow the use of genomics to reduce health inequities between rich and poor nations.

Entities:  

Mesh:

Year:  2002        PMID: 12084683      PMCID: PMC1447192          DOI: 10.2105/ajph.92.7.1077

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  14 in total

1.  Epidemiology set to get fast-track treatment.

Authors:  D Butler
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

2.  Intellectual property. Patents, secrecy, and DNA.

Authors:  R M Cook-Deegan; S J McCormack
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

3.  Science and development.

Authors:  D Kennedy
Journal:  Science       Date:  2001-12-07       Impact factor: 47.728

4.  Proposed genetic database on Tongans opposed.

Authors:  Bob Burton
Journal:  BMJ       Date:  2002-02-23

5.  Harnessing genomics and biotechnology to improve global health equity.

Authors:  P A Singer; A S Daar
Journal:  Science       Date:  2001-10-05       Impact factor: 47.728

6.  msJAMA. The role of genomics in public health and disease prevention.

Authors:  K K Steinberg; M Gwinn; M J Khoury
Journal:  JAMA       Date:  2001-10-03       Impact factor: 56.272

7.  Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial.

Authors:  K A Bojang; P J Milligan; M Pinder; L Vigneron; A Alloueche; K E Kester; W R Ballou; D J Conway; W H Reece; P Gothard; L Yamuah; M Delchambre; G Voss; B M Greenwood; A Hill; K P McAdam; N Tornieporth; J D Cohen; T Doherty
Journal:  Lancet       Date:  2001-12-08       Impact factor: 79.321

8.  Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs.

Authors:  H Jomaa; J Wiesner; S Sanderbrand; B Altincicek; C Weidemeyer; M Hintz; I Türbachova; M Eberl; J Zeidler; H K Lichtenthaler; D Soldati; E Beck
Journal:  Science       Date:  1999-09-03       Impact factor: 47.728

Review 9.  Plasmodium, human and Anopheles genomics and malaria.

Authors:  Stephen L Hoffman; G Mani Subramanian; Frank H Collins; J Craig Venter
Journal:  Nature       Date:  2002-02-07       Impact factor: 49.962

10.  Short cut to disease genes.

Authors:  A F Wright; V Van Heyningen
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

View more
  5 in total

1.  Ethics in public health institutions.

Authors:  Richard P Wedeen
Journal:  Am J Public Health       Date:  2002-12       Impact factor: 9.308

Review 2.  Health care policy issues as a result of the genetic revolution: implications for public health.

Authors:  Rohit P Ojha; Raymond Thertulien
Journal:  Am J Public Health       Date:  2005-03       Impact factor: 9.308

Review 3.  Genetics and public health--evolution, or revolution?

Authors:  Jane L Halliday; Veronica R Collins; Mary Anne Aitken; Martin P M Richards; Craig A Olsson
Journal:  J Epidemiol Community Health       Date:  2004-11       Impact factor: 3.710

4.  Community engagement about genetic variation research.

Authors:  Sharon F Terry; Kurt D Christensen; Susan Metosky; Gayle Rudofsky; Kathleen P Deignan; Hulda Martinez; Penelope Johnson-Moore; Toby Citrin
Journal:  Popul Health Manag       Date:  2011-08-04       Impact factor: 2.459

5.  Molecular genomic approaches to infectious diseases in resource-limited settings.

Authors:  Josefina Coloma; Eva Harris
Journal:  PLoS Med       Date:  2009-10-26       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.